表紙
市場調查報告書

全球子宮頸癌疫苗市場:產品類型,流通管道,各地區 - 規模,佔有率,趨勢,及預測

Cervical Cancer Vaccines Market, By Product Type, By Distribution Channel, and By Region - Size, Share, Trends, and Forecast 2018 - 2026

出版商 Coherent Market Insights 商品編碼 906230
出版日期 內容資訊 英文 145 Pages
商品交期: 2-3個工作天內
價格
Back to Top
全球子宮頸癌疫苗市場:產品類型,流通管道,各地區 - 規模,佔有率,趨勢,及預測 Cervical Cancer Vaccines Market, By Product Type, By Distribution Channel, and By Region - Size, Share, Trends, and Forecast 2018 - 2026
出版日期: 2019年07月30日內容資訊: 英文 145 Pages
簡介

本報告提供全球子宮頸癌疫苗市場的相關調查,提供市場趨勢和開發,成長及阻礙因素,產品類型·流通管道·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 調查的目的及假設

  • 調查目的
  • 假設
  • 簡稱

第2章 市場概要

  • 報告的說明
    • 市場定義及範圍
  • 摘要整理
    • 各產品類型
    • 各流通管道
    • 各地區
  • COM (Coherent Opportunity Map)

第3章 市場動態,法規,趨勢分析

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 市場趨勢
  • 主要的開發
  • 法規狀況
  • 產品回收
  • 流行病學分析
  • 技術概要
  • PEST分析
  • 波特的五力分析

第4章 子宮頸癌疫苗的全球市場:各產品類型

  • 簡介
  • Gardasil
  • Gardasil 9
  • Cervarix

第5章 子宮頸癌疫苗的全球市場:各流通管道

  • 簡介
  • 醫院
  • 診所
  • 政府機關

第6章 子宮頸癌疫苗的全球市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 非洲
  • 中東

第7章 競爭情形

  • 企業簡介
    • GlaxoSmithKline plc.
    • Merck & Co. Inc.
  • 分析師的見解

第8章 章節

  • 參照資料
  • 調查方法
  • 關於Coherent Market Insight
目錄

Title:
Cervical Cancer Vaccines Market, By Product Type (Cervarix, Gardasil, and Gardasil 9), By Distribution Channel (Hospitals, Clinics, and Government Entities), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast 2018 - 2026.

Cervical cancer is a common type of cancer occurring in women worldwide. A major cause of cervical cancer is infection by human papillomavirus (HPV), which is found in 99% cervical cancer. Human papillomavirus is sexually transmitted. Around 100 types of HPV have been identified to date, of which types 16 and 18 are believed to be responsible for more than 70% of cervical cancers. Cervarix and Gardasil are type of vaccines used for the treatment of cervical cancer.

Market Dynamics:

Increasing prevalence of cervical cancer worldwide is expected to boost the cervical cancer vaccines market growth. According to the World Health Organization (WHO), 2018, cervical cancer is the fourth most frequent cancer in women with an estimated 570,000 new cases and representing 6.6% of all female cancers worldwide and around 85% of deaths occur due to cervical cancer in developing countries.

However, lack of awareness amongst the people in the low-income and middle-income countries regarding cervical cancer is expected to hinder growth of the cervical cancer vaccines market during the forecast period. Cervical cancer is one of the most common cancers among women of reproductive age in low-income and middle-income countries. For instance, according to The International Agency for Research on Cancer's (IARC) report of 2013, cervical cancer is most notable in low-income countries of sub-Saharan Africa.

Key features of the study:

  • This report provides in-depth analysis of the global cervical cancer vaccines market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2019 - 2026, considering 2018 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the cervical cancer vaccines market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include, GlaxoSmithKline plc. And Merck & Co. Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The cervical cancer vaccines market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for immune repertoire sequencing market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Cervical Cancer Vaccines Market , By Product Type:
    • Gardasil
    • Gardasil 9
    • Cervarix
  • Global Cervical Cancer Vaccines Market, By Distribution Channel:
    • Hospitals
    • Clinics
    • Government Entities
  • Global Cervical Cancer Vaccines Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
      • By Product Type:
    • Gardasil
    • Gardasil 9
    • Cervarix
      • By Distribution Channel:
    • Hospitals
    • Clinics
    • Government Entities
    • Europe
      • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
      • By Product Type:
    • Gardasil
    • Gardasil 9
    • Cervarix
      • By Distribution Channel:
    • Hospitals
    • Clinics
    • Government Entities
    • Asia Pacific
      • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
      • By Product Type:
    • Gardasil
    • Gardasil 9
    • Cervarix
      • By Distribution Channel:
    • Hospitals
    • Clinics
    • Government Entities
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
      • By Product Type:
    • Gardasil
    • Gardasil 9
    • Cervarix
      • By Distribution Channel:
    • Hospitals
    • Clinics
    • Government Entities
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
      • By Product Type:
    • Gardasil
    • Gardasil 9
    • Cervarix
      • By Distribution Channel:
    • Hospitals
    • Clinics
    • Government Entities
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
      • By Product Type:
    • Gardasil
    • Gardasil 9
    • Cervarix
      • By Distribution Channel:
    • Hospitals
    • Clinics
    • Government Entities
  • Company Profiles
    • GlaxoSmithKline plc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Merck & Co. Inc.
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Landscape
  • Product Recall
  • Epidemiology Analysis
  • Technology Overview
  • PEST Analysis
  • Porter's Five Forces Model

4. Global Cervical Cancer Vaccines Market , By Product Type, 2019 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Gardasil
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Gardasil 9
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Cervarix
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)

5. Global Cervical Cancer Vaccines Market, By Distribution Channel, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)
  • Government Entities
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2026, (US$ Million)

6. Global Cervical Cancer Vaccines Market, By Region, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, By Region, 2017 - 2026
    • Regional Trends
  • North America
    • Market Size and Forecast, By Product Type, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Product Type, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Product Type, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Product Type, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, Distribution Channel, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Country/Region, 2018 - 2026, (US$ Million)
    • North Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Product Type, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2018 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2018 - 2026, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

7. Competitive Landscape

  • Company Profiles
    • GlaxoSmithKline plc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Merck & Co. Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Analyst Views

8. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Back to Top